AAO-HNS
  • Posters
  • Meeting Coverage
  • Conference Agenda
  • OTO Experience
  • How to Claim CME
Topics
  • Meeting Coverage
  • Conference Agenda
  • OTO Experience
  • How to Claim CME
Resources
  • Posters
Facebook iconInstagram iconTwitter iconYouTube icon
Sep 13th, 2022

New Consensus Statement Updates Management of Pediatric OSA after Adenotonsillectomy


Maturo, Ishman and Schwartz headshots
(From left) Steve C. Maturo, MD, Stacey L. Ishman, MD, MPH, and Seth R. Schwartz, MD, MPH

“Watch more, do less” is a key take-home message from the soon-to-be-published expert consensus statement (ESC) from the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) on the management of pediatric obstructive sleep apnea (OSA) after adenotonsillectomy. Not every child who has continuing obstructive symptoms after initial adenotonsillectomy needs or is likely to benefit from additional diagnostic procedures or additional medical or surgical treatment.   

“A lot of clinicians look at an Apnea-hypopnea index number after adenotonsillectomy and assume that child automatically needs additional treatment,” said Steve C. Maturo, MD, pediatric otolaryngologist with Maine Medical Partners, a department of Main Medical Center in Portland, Maine. “We don’t think that is the case. If a child has mild sleep apnea and is not having symptoms or other behavioral or quality of life issues, there is a good argument to be made for simply watching them.”    

Dr. Maturo was a member of the AAO-HNSF Expert Consensus Statement (ECS) Development Group that authored, “Management of Persistent Pediatric OSA After Adenotonsillectomy.” The ECS will be presented on Wednesday and will be published in an upcoming issue of Otolaryngology–Head and Neck Surgery. ECS Development Group Chair Stacey L. Ishman, MD, MPH, Professor of Otolaryngology, Head & Neck Surgery at Cincinnati Children’s’ Hospital in Ohio, will lead the presentation.          

Adenotonsillectomy remains the first-line treatment for pediatric OSA, but the initial surgery is not 100% curative. Depending on the study, between 10% and 60% of children have persistent OSA symptoms after adenotonsillectomy, said ECS Development Group member Seth R. Schwartz, MD, MPH, Director, Listen for Life Center, Virginia Mason Medical Center in Seattle, Washington. Children who are obese, have Down syndrome, or several other high-risk conditions are at higher risk for persistent symptoms and for more severe symptoms after adenotonsillectomy.       

“There was comfort with observing children who have asymptomatic, mild persistent sleep apnea after adenotonsillectomy because experience suggests they don’t necessarily benefit from intervention,” Dr. Schwartz said. “And there was agreement that for children with more severe symptoms or more severe sleep apnea or who have moderate to severe OSA and who have symptoms, those children should definitely be assessed and potentially treated.”           

Another important area of consensus is the need for multidisciplinary care for children with persistent OSA after initial surgery and the importance of shared decision-making.           

The ECS follows the 2021 ECS, Pediatric Drug-Induced Sleep Endoscopy (DISE). Both ESCs are intended to identify areas of variation and improve the quality of care for children with OSA. Some Development Group members, although not all, contributed to both statements. 

“Each child should be treated as an individual, not a number from a sleep study,” Dr. Maturo said. “We are also recognizing that there are effective medical and surgical treatment options for children who do have persistent sleep apnea. They don’t all need to be placed on CPAP (continuous positive air pressure).”          

There was also consensus that several other interventions are effective medical approaches for patients with persistent sleep apnea when targeted at the appropriate patient, including weight loss, leukotriene modifiers, nasal corticosteroids, and oral appliances. The group agreed that DISE is an effective way to identify residual areas of obstruction after adenotonsillectomy. There was consensus that several surgical procedures when directed at these identified sites of obstruction are safe and effective.

The tongue base and supraglottis are common sites of residual obstructed breathing during sleep. Supraglottoplasty, lingual tonsillectomy, and expansion pharyngoplasty can be effective in some children, depending on individual anatomical features and other factors, Dr. Maturo continued. In the pediatric Down syndrome population, there are data to support hypoglossal nerve stimulation.        

“Persistent OSA after adenotonsillectomy has been an under-addressed and under-managed problem in our specialty,” Dr. Schwartz said. “It has been something of a black box for some clinicians. We need more studies to fully open that black box, but until that happens, there is quite a lot of consensus among experts on how best to address these children.”

           

            

Expert Consensus Statement: Management of Persistent Pediatric OSA after Adenotonsillectomy:

Wednesday, September 14 | 9:15 - 10:15 am (ET)


Interesting Stories
Expert Consensus Statements
Sponsored by AAO-HNS
Expert Consensus Statements
More Content
Dr. Chelius group shot
Meeting Coverage
Same Time Next Year
Sep 13th, 2022
Orestes headshot
AAO-HNSF 2022
Session Features Feedback Fundamentals for Surgical Success
Sep 13th, 2022
Mehta, Langerman, Gibber headshots
Meeting Coverage
Updating Post-Residency Surgical Training for the Modern Era
Sep 13th, 2022
Harrill and Woodard headshots
Meeting Coverage
Meeting the Challenges in Value-Based Healthcare
Sep 13th, 2022
COVID-19 graphic
Meeting Coverage
COVID Implications for Otolaryngology
Sep 13th, 2022
laptop user
Meeting Coverage
Claim Your CME
Sep 13th, 2022
Krishna, Schmalbach, Russell headshots
Meeting Coverage
Surgeons Need to Stay Fit and Active to Stay Injury-Free
Sep 13th, 2022
Crosby, Glazer, Tillman and Kupfer headshots
Meeting Coverage
Removing Obstacles to Gender Bias in Otolaryngology
Sep 13th, 2022
Raynor and Lee headshots
Meeting Coverage
Harnessing Your Inner Taskmaster
Sep 13th, 2022
Cho and Turner headshots
Meeting Coverage
Don’t Take Your Writing for Granted
Sep 12th, 2022
From left to right, Clare Richardson, MD, Julianna Kostas, and Ernest D. Gomez, MD, MTR.
Meeting Coverage
SIM Tank Results
Sep 12th, 2022
Posters General 615b589360ac0
Meeting Coverage
2022 Scientific Poster Winners
Sep 12th, 2022
AAO-HNS
Facebook iconInstagram iconTwitter iconYouTube icon
© 2023 Ascend Media. All rights reserved.